Impact of HAT 2 CH 2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction
Angiology · 2024
DOI: 10.1177/00033197231171235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angiology, 2024. Verfasst von Hazar Harbalıoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hatay Iskenderun State Hospital, Hatay, Turkey. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, No-Reflow Phenomenon, Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
The HAT 2 CH 2 score [Hypertension (1 point), Age > 75 years (1 point), Stroke/Transient ischemic attack (2 points), Chronic obstructive pulmonary disease (1 point), and Heart failure (2 points)] was originally developed to predict the occurrence of new-onset atrial fibrillation. The aim of the present study was to examine whether this score could predict the development of no-reflow phenomenon (NR) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). Patients (n = 1552) with STEMI were consecutively enrolled in this single-center retrospective study. The SYNTAX score (SXscore) and HAT 2 CH 2 score were calculated. The presence of thrombolysis in myocardial infarction (TIMI) score ≤2, without significant residual stenosis and mechanical obstruction, indicated the presence of NR. The HAT 2 CH 2 score was significantly higher in the NR (+) group compared with the NR (−) group [2.29 ± 1.43 vs 1.46 ± 1.24, p < .001]. In multivariable logistic regression analysis, the HAT 2 CH 2 score [OR = 1.585, p < .001] and SXscore [OR = 1.028, p = .017] were found to be independent predictors of NR. Receiver operating characteristic curve analysis showed that the HAT 2 CH 2 score with a cutoff value of >2 determined NR, with 50.2% sensitivity and 79.4% specificity (AUC = .669, p < .001). In conclusion, the HAT 2 CH 2 score may facilitate risk stratification in estimating NR in STEMI patients undergoing pPCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hatay Iskenderun State Hospital, Hatay, Turkey.
- Department of Cardiology, Basaksehir Cam & Sakura City Hospital, Istanbul, Turkey.
- University of Health Sciences, Department of Cardiology, Adana City Training & Research Hospital, Adana, Turkey.
- Department of Cardiology, Medline Adana Hospital, Adana, Turkey.
ORCID-Profile: Hazar Harbalıoğlu, Ömer Genç, Alaa Quisi, Abdullah Yıldırım
Zitieren
APA
Harbalıoğlu, H., Genç, Ö., Alıcı, G., Quisi, A., & Yıldırım, A. (2024). Impact of HAT 2 CH 2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction. Angiology. https://doi.org/10.1177/00033197231171235
Vancouver
Harbalıoğlu H, Genç Ö, Alıcı G, Quisi A, Yıldırım A. Impact of HAT 2 CH 2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction. Angiology. 2024. doi:10.1177/00033197231171235
BibTeX
@article{Harbalolu2024,
author = {Harbalıoğlu, Hazar and Genç, Ömer and Alıcı, Gökhan and Quisi, Alaa and Yıldırım, Abdullah},
title = {Impact of HAT 2 CH 2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction},
journal = {Angiology},
year = {2024},
doi = {10.1177/00033197231171235}
}
EUVIMED